Author:
Zhang Qingpeng,Yang Jiannan,Zeng Daniel Dajun,Feng Yibin,Wong Ian C.K.
Reference8 articles.
1. National Health Commission of China, Announcement of the Further Adjustment of COVID-19 Restrictions, 2022. URL: 〈http://www.nhc.gov.cn/xcs/gzzcwj/202212/8278e7a7aee34e5bb378f0e0fc94e0f0.shtml〉.
2. Strengthening public health systems in China;Meng;Lancet Public Health,2022
3. Estimating the transmission dynamics of SARS-CoV-2 Omicron BF. 7 in Beijing after the adjustment of zero-COVID policy in November-December 2022;Leung;Nat. Med.,2023
4. D. Hodge, F. Marra, C. Marzolini, A. Boyle, S. Gibbons, M. Siccardi, S. Khoo, Drug interactions: a review of the unseen danger of experimental COVID-19 therapies, J. Antimicrob. Chemother., 75(12), 2020, pp. 3417–3424.
5. Potential herb-drug interactions between anti-COVID-19 drugs and traditional Chinese medicine;Ye;Acta Pharm. Sin. B,2023